Starting Treatment
with ABRILADA

Not actual patients.

people talking
people talking

Designed with you in mind

citrate-free icon

Citrate-free formulation

May reduce injection-site pain

manufacturing icon

Made without natural
rubber latex

May reduce the likelihood
of an allergic reaction

out-of-fridge icon

Must be refrigerated. If needed, can be stored outside of the refrigerator for up to 30 days at room temperature*

To give you travel flexibility

* Store ABRILADA in the refrigerator at 36ºF to 46ºF (2ºC to 8ºC). Do not freeze. Always keep in the carton until use to protect from light.
Room temperature is up to 86º F (30ºC). Throw away ABRILADA if it has been kept at room temperature and not been used within 30 days.

ABRILADA is available in prefilled, single-dose pens and syringes

prefilled pen

  • Cap
  • Window
  • Injection button

Window allows visual inspection of your medicine and its delivery

Medicine is delivered in
3-10 seconds after the injection button is pressed

Audible clicks signal start and finish of your medicine delivery

  • You may be able to give the ABRILADA injection to yourself (after receiving a demonstration from your healthcare professional), or it may be given by your healthcare professional. Your doctor or healthcare professional will decide which is right for you
  • Your doctor will also determine the right dose of ABRILADA and how often you should receive it. This is based on your condition being treated

Feel confident injecting ABRILADA

Pfizer provides a range of injection education resources for you (and your caregiver)

See the full Medication Guide and Instructions for Use inside the carton for complete instructions to properly prepare and inject ABRILADA

Access support

COMING SOON

Know what to expect

Once you’ve been prescribed ABRILADA, it will be filled through a specialty pharmacy

Learn more about specialty pharmacies and how you’ll receive your medication

Download the guide

How ABRILADA works

ABRILADA is a biologic treatment that is approved to treat certain inflammatory conditions. ABRILADA is a biosimilar — a highly similar version of Humira® (adalimumab), a biologic medicine that has been available for some time. A biosimilar is approved by the US Food & Drug Administration (FDA) only after it has been found to have no clinically meaningful differences from the original biologic medicine.

ABRILADA is expected to work the same way Humira® does

  • ABRILADA blocks the action of a protein in the body called tumor necrosis factor-alpha (TNF-alpha)
  • TNF-alpha is made by your body's immune system. People with certain diseases have too much TNF-alpha that can cause the immune system to attack normal healthy parts of the body
  • ABRILADA works by blocking TNF-alpha, which in excess amounts can cause inflammation

without ABRILADA MOA image

with ABRILADA MOA image